Our Services

From regulatory strategy
to audit-ready execution

Development

Biomedical development support for spin-offs, start-ups, entrepreneurs and research centers—linking scientific development with regulated evidence generation.

  • Product concept → regulated plan (requirements, evidence roadmap)
  • Clinical/performance evidence planning aligned with intended purpose
  • Cross-functional documentation alignment (R&D ↔ QA/RA ↔ Clinical)

Regulations

Regulatory matters and quality assurance for pharmaceutical, medical device and IVD companies—focused on practical execution and audit readiness.

  • IVD registration strategy and technical documentation leadership
  • QMS and standards readiness: ISO 13485/9001, ISO 15189, 21 CFR 820
  • Clinical/regulatory medical writing: protocols/CTPs, IMPDs, CSRs, narratives

Representation (EC REP)

Authorised EU representative (EC REP) for medical devices and IVD, supporting compliant communication and defined responsibilities under EU regulations.

The scope and obligations of an authorised representative are defined by EU rules; we work strictly within that framework.

Research

Organization of clinical research with a comprehensive portfolio of services that can be customized to each project—covering start-up, oversight and coordination.

  • Study start-up, logistics and trial management delivery
  • Experience across broad therapeutic areas (oncology, neurology, cardiology, respiratory, psychiatry, etc.)
  • IVD/MD performance and evaluation study support (selected examples available on request)
Micro-Case Studies

Selected Project
Highlights

MDR Remediation

MDR risk management remediation and audit readiness (process updates, RMF refresh, QC review measures).

IVD Regulatory Leadership

IVD registration strategy and technical documentation ownership, including ISO 15189-focused accreditation work and validation leadership.

First-in-Country Approvals

First approved and conducted pediatric Phase I clinical trial in Slovakia (2010) and first fully approved and conducted Phase I GMO clinical trial in Slovakia (2023).

kontaktný formular

Get in Touch

    Tell us what you're building (MD/IVD/biopharma), your current lifecycle stage, and the jurisdiction focus—we'll reply with clear next steps.